Overview
Date/time interval
Secondo Semestre (02/03/2026 - 19/06/2026)
Syllabus
Course Objectives
Clinical pharmacy is a reality now established in several European countries and overseas. The revolution compared to the approach
is the classic shift of the pharmacist’s attention from the single drug to the patient’s health. The view of the
The clinical is therefore no longer pharmacocentric but has as its epicentre the well-being of the patient or, more generally, the population in
Treatment with drugs.
It is a discipline that is carried out in hospitals, community and territorial pharmacies and in any area where they are
Medicines and medical devices are studied, prescribed, dispensed and recommended. Clinical pharmacists treat patients in any
health, as they possess - in addition to the established basic knowledge related especially to the mechanism of action and
drug formulation - new expertise in clinical and biomedical issues.
In the health contexts where it is applied, clinical pharmacy allows to optimize the patient’s medical therapy and promote
Health, well-being and disease prevention. It also contributes to the generation of new knowledge that can improve
Health and quality of life.
This teaching activity is proposed on the basis of specific contacts with ITALIAN and EUROPEAN SOCIETIES and on the encouragement of students who have asked to be trained in an up-to-date way to this professional.
Clinical pharmacy is a well-established reality in several European countries and overseas. The revolution compared to the classic approach is the shift of the pharmacist’s attention from the single drug to the patient’s health. The clinical pharmacist’s vision is no longer pharmacocentric but has as its epicentre the patient’s well-being or, more generally, the population under treatment with drugs. It is a discipline that is carried out in hospitals, community and territorial pharmacies and in any area where medicines and medical devices are studied, prescribed, dispensed and recommended. Clinical pharmacists treat patients in any health care setting, because they have - in addition to the established basic knowledge related mainly to the mechanism of action and formulation of drugs - new skills in clinical and biomedical.Enable the student to carry out theoretical and practical activities so as to be able to understand the future role of the clinical pharmacist in hospitals and on the territory and the performances that the new post-Covid era pharmacist must have and know and practice. The new SSN and SSR requires a new, innovative and correct clinical training and it is necessary to start from the University and with students.
Clinical pharmacists in the world collaborate with doctors (in italy this discipline is currently under development). Clinical pharmacists have extensive training in biomedical, pharmaceutical, pharmacoepidemiological and clinical sciences and also be prepared to face small emergencies in the territory and use devices (POC) point of care to make minidiagnosi onsite immediately and then do or propose appropriate therapies for minor ailments on the territory or interact with other health professionals in the team that manages the patient in hospital, especially now with innovative biological drugs. The functional area of Clinical Pharmacy is responsible for coordinating all pharmaceutical activities aimed at promoting a rational and appropriate use of the drug and aimed at disseminating knowledge useful to improve the selection process, Prescription and use of the drug, diagnostic and medical device. In particular, within the area of Clinical Pharmacy, emphasis is placed on the monitoring and evaluation of therapies, with the objective of promoting appropriate and uniform behaviors within specific clinical - therapeutic areas. The aim of Clinical Pharmacy is to ensure the safe and effective use of drugs, dealing with clinical pharmacology, counseling, pharmacovigilance and pharmaceutical technology. In fact, besides the appropriate choice of the drug to be administered, the factors that contribute to make a therapy optimal are also the monitoring of tolerability and adverse effects, The adoption of safe delivery systems and attention to possible practical problems related to the patient’s own delivery.
The term "clinic" does not necessarily imply an activity within a hospital environment, but it wants to emphasize the fact that the activity carried out is related to the patient’s health. This means that all pharmacists, both community and hospital pharmacists, are able to carry out the activities of clinical pharmacy when they have a high professional university training.
The course will have a theoretical and practical part related to the REVAPOCT COURSE offered to students.
is the classic shift of the pharmacist’s attention from the single drug to the patient’s health. The view of the
The clinical is therefore no longer pharmacocentric but has as its epicentre the well-being of the patient or, more generally, the population in
Treatment with drugs.
It is a discipline that is carried out in hospitals, community and territorial pharmacies and in any area where they are
Medicines and medical devices are studied, prescribed, dispensed and recommended. Clinical pharmacists treat patients in any
health, as they possess - in addition to the established basic knowledge related especially to the mechanism of action and
drug formulation - new expertise in clinical and biomedical issues.
In the health contexts where it is applied, clinical pharmacy allows to optimize the patient’s medical therapy and promote
Health, well-being and disease prevention. It also contributes to the generation of new knowledge that can improve
Health and quality of life.
This teaching activity is proposed on the basis of specific contacts with ITALIAN and EUROPEAN SOCIETIES and on the encouragement of students who have asked to be trained in an up-to-date way to this professional.
Clinical pharmacy is a well-established reality in several European countries and overseas. The revolution compared to the classic approach is the shift of the pharmacist’s attention from the single drug to the patient’s health. The clinical pharmacist’s vision is no longer pharmacocentric but has as its epicentre the patient’s well-being or, more generally, the population under treatment with drugs. It is a discipline that is carried out in hospitals, community and territorial pharmacies and in any area where medicines and medical devices are studied, prescribed, dispensed and recommended. Clinical pharmacists treat patients in any health care setting, because they have - in addition to the established basic knowledge related mainly to the mechanism of action and formulation of drugs - new skills in clinical and biomedical.Enable the student to carry out theoretical and practical activities so as to be able to understand the future role of the clinical pharmacist in hospitals and on the territory and the performances that the new post-Covid era pharmacist must have and know and practice. The new SSN and SSR requires a new, innovative and correct clinical training and it is necessary to start from the University and with students.
Clinical pharmacists in the world collaborate with doctors (in italy this discipline is currently under development). Clinical pharmacists have extensive training in biomedical, pharmaceutical, pharmacoepidemiological and clinical sciences and also be prepared to face small emergencies in the territory and use devices (POC) point of care to make minidiagnosi onsite immediately and then do or propose appropriate therapies for minor ailments on the territory or interact with other health professionals in the team that manages the patient in hospital, especially now with innovative biological drugs. The functional area of Clinical Pharmacy is responsible for coordinating all pharmaceutical activities aimed at promoting a rational and appropriate use of the drug and aimed at disseminating knowledge useful to improve the selection process, Prescription and use of the drug, diagnostic and medical device. In particular, within the area of Clinical Pharmacy, emphasis is placed on the monitoring and evaluation of therapies, with the objective of promoting appropriate and uniform behaviors within specific clinical - therapeutic areas. The aim of Clinical Pharmacy is to ensure the safe and effective use of drugs, dealing with clinical pharmacology, counseling, pharmacovigilance and pharmaceutical technology. In fact, besides the appropriate choice of the drug to be administered, the factors that contribute to make a therapy optimal are also the monitoring of tolerability and adverse effects, The adoption of safe delivery systems and attention to possible practical problems related to the patient’s own delivery.
The term "clinic" does not necessarily imply an activity within a hospital environment, but it wants to emphasize the fact that the activity carried out is related to the patient’s health. This means that all pharmacists, both community and hospital pharmacists, are able to carry out the activities of clinical pharmacy when they have a high professional university training.
The course will have a theoretical and practical part related to the REVAPOCT COURSE offered to students.
Course Prerequisites
Knowledge of anatomy, physiology, pharmacology.
The activity is aimed at students of the Pharmacy and CTF course to prepare them for the future work challenges of the post-Covid era. Clinical Pharmacy is the branch of pharmacy that specializes in pharmacists providing assistance to patients with optimizing drug use and promoting health, well-being and disease prevention. It is an activity carried out in the territory and in the hospital, requiring theoretical, cultural, scientific and practical preparation.
Students who want to take the course of Clinical Pharmacy, should have taken the exams of General Pharmacology, Pharmacology and Pharmacotherapy, Pharmaceutical Chemistry and Technical and Pharmaceutical Legislation
Clinical pharmacy comprises a number of functions that promote the safe, effective and cost-effective use of drugs for individual patients.
• The emergence of clinical pharmacy has allowed pharmacists to shift from a product-oriented role towards direct involvement with patients and the problems they encounter with drugs.
Clinical pharmacy practice is generally an essential component of pharmaceutical care.
• Pharmaceutical care is a cooperative, patient-centred system for achieving specific and positive patient outcomes from responsible drug delivery.
The three key elements of the care process are patient assessment, determination of the care plan and evaluation of outcomes.
• The ability to consult patients is a key process in the delivery of pharmaceutical care and requires regular review and development regardless of experience.
• The clinical pharmacy process has been incorporated into a professional development framework that can be used to improve skills and knowledge.
The activity is aimed at students of the Pharmacy and CTF course to prepare them for the future work challenges of the post-Covid era. Clinical Pharmacy is the branch of pharmacy that specializes in pharmacists providing assistance to patients with optimizing drug use and promoting health, well-being and disease prevention. It is an activity carried out in the territory and in the hospital, requiring theoretical, cultural, scientific and practical preparation.
Students who want to take the course of Clinical Pharmacy, should have taken the exams of General Pharmacology, Pharmacology and Pharmacotherapy, Pharmaceutical Chemistry and Technical and Pharmaceutical Legislation
Clinical pharmacy comprises a number of functions that promote the safe, effective and cost-effective use of drugs for individual patients.
• The emergence of clinical pharmacy has allowed pharmacists to shift from a product-oriented role towards direct involvement with patients and the problems they encounter with drugs.
Clinical pharmacy practice is generally an essential component of pharmaceutical care.
• Pharmaceutical care is a cooperative, patient-centred system for achieving specific and positive patient outcomes from responsible drug delivery.
The three key elements of the care process are patient assessment, determination of the care plan and evaluation of outcomes.
• The ability to consult patients is a key process in the delivery of pharmaceutical care and requires regular review and development regardless of experience.
• The clinical pharmacy process has been incorporated into a professional development framework that can be used to improve skills and knowledge.
Teaching Methods
Depending on the context, different methods may be used, given the complexity of the subject and using Bloom’s taxonomy.
-lectures
Role-play method and student-teacher
-simulations
-Clinical cases
-Examples of experiences carried out
-practical activity
-Looking ahead
-Direct observation
-Point teaching (JiTT)
-Public response system (ARS)
-Teaching in the classroom upside down
- Snowball sampling technique
-Standardized patients
-ASK-TELL-ASK FEEDBACK method
-RECONCILIATION OF INFORMATION: S-A-L-S-A (Share-Ask-Listen-Share Again-AskAgain)
-Pose-Pause-Pounce-Bounce method
-See one, do one, teach advanced technology in medical teaching.
-lectures
Role-play method and student-teacher
-simulations
-Clinical cases
-Examples of experiences carried out
-practical activity
-Looking ahead
-Direct observation
-Point teaching (JiTT)
-Public response system (ARS)
-Teaching in the classroom upside down
- Snowball sampling technique
-Standardized patients
-ASK-TELL-ASK FEEDBACK method
-RECONCILIATION OF INFORMATION: S-A-L-S-A (Share-Ask-Listen-Share Again-AskAgain)
-Pose-Pause-Pounce-Bounce method
-See one, do one, teach advanced technology in medical teaching.
Assessment Methods
- Briefing e discussione a piccoli gruppi
-Feedback degli studenti
-Audit
-Test finale
-ASK-TELL-ASK FEEDBACK method
-INFORMATION RECONCILIATION: S-A-L-S-A (Share-Ask-Listen-Share Again-AskAgain)
-OSCE
-Feedback degli studenti
-Audit
-Test finale
-ASK-TELL-ASK FEEDBACK method
-INFORMATION RECONCILIATION: S-A-L-S-A (Share-Ask-Listen-Share Again-AskAgain)
-OSCE
Texts
Clinical Pharmacy and Therapeutics E-Book 6th Edition 2019, a cura di Cate Whittlesea, Karen Dr Hodson
Clinical Pharmacy and Therapeutics, 5e
Modern Drug Delivery Systems: Technology, Clinical Pharmaceutics, and Use in Practice
Taylor & Francis Inc , 2023, Edizione Inglese di Roger Walker BPharm PhD FRPharmS FFPH (a cura di), Cate Whittlesea BSc MSc PhD MRPharm
Telemedicine: Pediatric Applications.
Burke BL Jr, Hall RW; SECTION ON TELEHEALTH CARE.Pediatrics. 2015 Jul;136(1):e293-308. doi: 10.1542/peds.2015-1517.PMID: 26122813
Telemedicine: a Primer.
Waller M, Stotler C.Curr Allergy Asthma Rep. 2018 Aug 25;18(10):54. doi: 10.1007/s11882-018-0808-4.PMID: 30145709
Ethical practice in Telehealth and Telemedicine.
Chaet D, Clearfield R, Sabin JE, Skimming K; Council on Ethical and Judicial Affairs American Medical Association.J Gen Intern Med. 2017 Oct;32(10):1136-1140. doi: 10.1007/s11606-017-4082-2. Epub 2017 Jun 26.PMID: 28653233
Effectiveness of telemedicine: a systematic review of reviews.
Ekeland AG, Bowes A, Flottorp S.Int J Med Inform. 2010 Nov;79(11):736-71. doi: 10.1016/j.ijmedinf.2010.08.006.PMID: 20884286
Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices.
Weinstein RS, Krupinski EA, Doarn CR.Med Clin North Am. 2018 May;102(3):533-544. doi: 10.1016/j.mcna.2018.01.002.PMID: 29650074
Telemedicine for Developing Countries. A Survey and Some Design Issues.
Combi C, Pozzani G, Pozzi G.Appl Clin Inform. 2016 Nov 2;7(4):1025-1050. doi: 10.4338/ACI-2016-06-R-0089.PMID: 27803948
[Nursing care in telemedicine and telehealth across the world].
Bartz CC.Soins. 2016 Nov;61(810):57-59. doi: 10.1016/j.soin.2016.09.013.PMID: 27894484
Cost-utility and cost-effectiveness studies of telemedicine, electronic, and mobile health systems in the literature: a systematic review.
de la Torre-Díez I, López-Coronado M, Vaca C, Aguado JS, de Castro C.Telemed J E Health. 2015 Feb;21(2):81-5. doi: 10.1089/tmj.2014.0053. Epub 2014 Dec 4.PMID: 25474190
Telepharmacy: A New Paradigm for Our Profession.
Le T, Toscani M, Colaizzi J.J Pharm Pract. 2020 Apr;33(2):176-182. doi: 10.1177/0897190018791060. Epub 2018 Jul 30.PMID: 30060679
Telepharmacy Services: Present Status and Future Perspectives: A Review.
Baldoni S, Amenta F, Ricci G.Medicina (Kaunas). 2019 Jul 1;55(7):327. doi: 10.3390/medicina55070327.PMID: 31266263
Telepharmacy for the management of cardiovascular patients in the community.
Omboni S, Tenti M.Trends Cardiovasc Med. 2019 Feb;29(2):109-117. doi: 10.1016/j.tcm.2018.07.002. Epub 2018 Jul 12.PMID: 30037524
Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges.
Poudel A, Nissen LM.Integr Pharm Res Pract. 2016 Oct 26;5:75-82. doi: 10.2147/IPRP.S101685. eCollection 2016.PMID: 29354542
Expansion of Telemedicine Services: Telepharmacy, Telestroke, Teledialysis, Tele-Emergency Medicine.
Kane-Gill SL, Rincon F.Crit Care Clin. 2019 Jul;35(3):519-533. doi: 10.1016/j.ccc.2019.02.007. Epub 2019 Apr 7.PMID: 31076051
Telepharmacy in oncology care: A scoping review.
Vo AT, Gustafson DL.J Telemed Telecare. 2020 Dec 30:1357633X20975257. doi: 10.1177/1357633X20975257. Online ahead of print.PMID: 33377820
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.
Margusino-Framiñán L, Illarro-Uranga A, Lorenzo-Lorenzo K, Monte-Boquet E, Márquez-Saavedra E, Fernández-Bargiela N, Gómez-Gómez D, Lago-Rivero N, Poveda-Andrés JL, Díaz-Acedo R, Hurtado-Bouza JL, Sánchez-Gundín J, Casanova-Martínez C, Morillo-Verdugo R.Farm Hosp. 2020 Jun 13;44(7):61-65. doi: 10.7399/fh.11498.PMID: 32533674
Telepharmacy and medication adherence in urban areas.
Guadamuz JS, McCormick CD, Choi S, Urick B, Alexander GC, Qato DM.J Am Pharm Assoc (2003). 2020 Nov 24:S1544-3191(20)30542-2. doi: 10.1016/j.japh.2020.10.017. Online ahead of print.PMID: 33246835
Clinical Pharmacy and Therapeutics, 5e
Modern Drug Delivery Systems: Technology, Clinical Pharmaceutics, and Use in Practice
Taylor & Francis Inc , 2023, Edizione Inglese di Roger Walker BPharm PhD FRPharmS FFPH (a cura di), Cate Whittlesea BSc MSc PhD MRPharm
Telemedicine: Pediatric Applications.
Burke BL Jr, Hall RW; SECTION ON TELEHEALTH CARE.Pediatrics. 2015 Jul;136(1):e293-308. doi: 10.1542/peds.2015-1517.PMID: 26122813
Telemedicine: a Primer.
Waller M, Stotler C.Curr Allergy Asthma Rep. 2018 Aug 25;18(10):54. doi: 10.1007/s11882-018-0808-4.PMID: 30145709
Ethical practice in Telehealth and Telemedicine.
Chaet D, Clearfield R, Sabin JE, Skimming K; Council on Ethical and Judicial Affairs American Medical Association.J Gen Intern Med. 2017 Oct;32(10):1136-1140. doi: 10.1007/s11606-017-4082-2. Epub 2017 Jun 26.PMID: 28653233
Effectiveness of telemedicine: a systematic review of reviews.
Ekeland AG, Bowes A, Flottorp S.Int J Med Inform. 2010 Nov;79(11):736-71. doi: 10.1016/j.ijmedinf.2010.08.006.PMID: 20884286
Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices.
Weinstein RS, Krupinski EA, Doarn CR.Med Clin North Am. 2018 May;102(3):533-544. doi: 10.1016/j.mcna.2018.01.002.PMID: 29650074
Telemedicine for Developing Countries. A Survey and Some Design Issues.
Combi C, Pozzani G, Pozzi G.Appl Clin Inform. 2016 Nov 2;7(4):1025-1050. doi: 10.4338/ACI-2016-06-R-0089.PMID: 27803948
[Nursing care in telemedicine and telehealth across the world].
Bartz CC.Soins. 2016 Nov;61(810):57-59. doi: 10.1016/j.soin.2016.09.013.PMID: 27894484
Cost-utility and cost-effectiveness studies of telemedicine, electronic, and mobile health systems in the literature: a systematic review.
de la Torre-Díez I, López-Coronado M, Vaca C, Aguado JS, de Castro C.Telemed J E Health. 2015 Feb;21(2):81-5. doi: 10.1089/tmj.2014.0053. Epub 2014 Dec 4.PMID: 25474190
Telepharmacy: A New Paradigm for Our Profession.
Le T, Toscani M, Colaizzi J.J Pharm Pract. 2020 Apr;33(2):176-182. doi: 10.1177/0897190018791060. Epub 2018 Jul 30.PMID: 30060679
Telepharmacy Services: Present Status and Future Perspectives: A Review.
Baldoni S, Amenta F, Ricci G.Medicina (Kaunas). 2019 Jul 1;55(7):327. doi: 10.3390/medicina55070327.PMID: 31266263
Telepharmacy for the management of cardiovascular patients in the community.
Omboni S, Tenti M.Trends Cardiovasc Med. 2019 Feb;29(2):109-117. doi: 10.1016/j.tcm.2018.07.002. Epub 2018 Jul 12.PMID: 30037524
Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges.
Poudel A, Nissen LM.Integr Pharm Res Pract. 2016 Oct 26;5:75-82. doi: 10.2147/IPRP.S101685. eCollection 2016.PMID: 29354542
Expansion of Telemedicine Services: Telepharmacy, Telestroke, Teledialysis, Tele-Emergency Medicine.
Kane-Gill SL, Rincon F.Crit Care Clin. 2019 Jul;35(3):519-533. doi: 10.1016/j.ccc.2019.02.007. Epub 2019 Apr 7.PMID: 31076051
Telepharmacy in oncology care: A scoping review.
Vo AT, Gustafson DL.J Telemed Telecare. 2020 Dec 30:1357633X20975257. doi: 10.1177/1357633X20975257. Online ahead of print.PMID: 33377820
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.
Margusino-Framiñán L, Illarro-Uranga A, Lorenzo-Lorenzo K, Monte-Boquet E, Márquez-Saavedra E, Fernández-Bargiela N, Gómez-Gómez D, Lago-Rivero N, Poveda-Andrés JL, Díaz-Acedo R, Hurtado-Bouza JL, Sánchez-Gundín J, Casanova-Martínez C, Morillo-Verdugo R.Farm Hosp. 2020 Jun 13;44(7):61-65. doi: 10.7399/fh.11498.PMID: 32533674
Telepharmacy and medication adherence in urban areas.
Guadamuz JS, McCormick CD, Choi S, Urick B, Alexander GC, Qato DM.J Am Pharm Assoc (2003). 2020 Nov 24:S1544-3191(20)30542-2. doi: 10.1016/j.japh.2020.10.017. Online ahead of print.PMID: 33246835
Contents
The program will be developed and carried out in theory and practice with the collaboration of various expert teachers trying to define the ROLE AND COMPETENCE OF THE CLINICAL PHARMACIST HOSPITAL AND ON THE TERRITORY and to point out essential topics such as:
-Prescription of drugs
-Administration of drugs
-Documentation of professional services
-Review of therapies
-Communication
-Counselling
-Consulting
-Prevention of therapeutic errors
-Information on drugs and therapies
-Use of the drugs
-Evaluation and selection of drugs
-Management of pharmacotherapy
-Education and training of formal programmes
-Management of the disease status
-Electronic data processing (EDP)
-Telemedicine
-Telepharmacy
-Implement pharmacists' skills to provide assistance and services to the population
-Develop and implement a program that trains students to interact with doctors and other healthcare
-Determine whether the drugs are optimally prescribed and meet the patient’s care needs and goals
-Assessing the adequacy and effectiveness of patient’s medications Knowing how to manage appropriate drug therapy
-Interact with physicians and other health care providers to monitor the drug therapy that best meets patient needs and effectively contributes to the achievement of overall therapy goals.
-Role of the pharmacist in therapeutic adherence,
-Chronic patient management in pharmacy with particular attention to categories such as the elderly, the child, pregnant women,
-The pharmacist’s advice on drugs and supplements,
-Monitoring of interactions, therapeutic reconciliation,
-POC and POCT
Other PROGRAMME TOPICS ARE Pharmacotherapy and pharmaceutical care
Pharmacotherapy and pharmaceutical care are taught in an integrated way within this component of the programme. Pharmaceutical care is the responsible provision of prescribed or non-prescription medicines, with a view to achieving, in consultation with other healthcare providers and with the patient, general health objectives, such as prevention, identification and resolution of problems associated with the use of medicinal products. Pharmaceutical care aims to continuously improve the use of medicines and to preserve or improve the quality of life of patients. Inter-professional consultation includes, among other things, referral to a doctor and information of the attending physician.
This component of the programme is taught as much as possible on the basis of the most common syndromes. The medicinal products which can be treated, whether for personal use or prescription, are discussed in detail, with particular emphasis on advice for responsible use of medicinal products.
The following topics are discussed:
(1) Indications, dosage and time of administration of the medicinal products.
(2) Therapeutic structure and initiation of treatment.
(3) Side effects of medicinal products and treatment.
(4) Drug interactions (clinical relevance, explanation, alternative proposal) and interactions with nutrition.
(5) Comparison of medicinal products within a class. Guidance to justify a particular choice.
(6) Co-morbidity.
(7) Contraindications.
(8) Refusal and/or switch to another medicinal product.
(9) New medicinal products included in a class.
(10) Drug monitoring and adherence to therapies.
(11) Use of medicinal products during pregnancy and lactation.
These topics will also be discussed:
(1) Indications, dosage and timing of the medicinal products.
(2) Initiation and pharmacotherapy strategies.
(3) Side effects of drugs and their treatment.
(4) Drug-drug and drug-food interactions (clinical relevance, mechanism, solution)
(5) Comparison by class and selection of medicinal products.
(6) Co-morbidity.
(7) Contraindications.
(8) Reduction and replacement of medicinal products.
(9) New medicinal products, preparations.
(10) Drug monitoring and adherence.
(11) Use of drugs during lactation.
(12) Children and medicines.
(13) Pharmacotherapy for the elderly, development of forms.
(14) Ocular pharmacotherapy (guest rapporteur)
(15) Drug and drug addiction treatment.
(16) Hormone drugs, including contraception.
(17) Pharmacotherapy of transplant and dialysis patients.
(18) Therapy and pharmacotherapy of multiple sclerosis.
(19) Medicinal products used in a palliative context.
(20) Inflammatory bowel disease (IBD) en Irritable Bowel Syndrome (IBS) pharmacotherapy.
(21) Pharmacotherapy of mucoviscidosis.
(22) Sport and doping.
The course will have a theoretical and practical part related to the REVAPOCT COURSE offered to students.
-Prescription of drugs
-Administration of drugs
-Documentation of professional services
-Review of therapies
-Communication
-Counselling
-Consulting
-Prevention of therapeutic errors
-Information on drugs and therapies
-Use of the drugs
-Evaluation and selection of drugs
-Management of pharmacotherapy
-Education and training of formal programmes
-Management of the disease status
-Electronic data processing (EDP)
-Telemedicine
-Telepharmacy
-Implement pharmacists' skills to provide assistance and services to the population
-Develop and implement a program that trains students to interact with doctors and other healthcare
-Determine whether the drugs are optimally prescribed and meet the patient’s care needs and goals
-Assessing the adequacy and effectiveness of patient’s medications Knowing how to manage appropriate drug therapy
-Interact with physicians and other health care providers to monitor the drug therapy that best meets patient needs and effectively contributes to the achievement of overall therapy goals.
-Role of the pharmacist in therapeutic adherence,
-Chronic patient management in pharmacy with particular attention to categories such as the elderly, the child, pregnant women,
-The pharmacist’s advice on drugs and supplements,
-Monitoring of interactions, therapeutic reconciliation,
-POC and POCT
Other PROGRAMME TOPICS ARE Pharmacotherapy and pharmaceutical care
Pharmacotherapy and pharmaceutical care are taught in an integrated way within this component of the programme. Pharmaceutical care is the responsible provision of prescribed or non-prescription medicines, with a view to achieving, in consultation with other healthcare providers and with the patient, general health objectives, such as prevention, identification and resolution of problems associated with the use of medicinal products. Pharmaceutical care aims to continuously improve the use of medicines and to preserve or improve the quality of life of patients. Inter-professional consultation includes, among other things, referral to a doctor and information of the attending physician.
This component of the programme is taught as much as possible on the basis of the most common syndromes. The medicinal products which can be treated, whether for personal use or prescription, are discussed in detail, with particular emphasis on advice for responsible use of medicinal products.
The following topics are discussed:
(1) Indications, dosage and time of administration of the medicinal products.
(2) Therapeutic structure and initiation of treatment.
(3) Side effects of medicinal products and treatment.
(4) Drug interactions (clinical relevance, explanation, alternative proposal) and interactions with nutrition.
(5) Comparison of medicinal products within a class. Guidance to justify a particular choice.
(6) Co-morbidity.
(7) Contraindications.
(8) Refusal and/or switch to another medicinal product.
(9) New medicinal products included in a class.
(10) Drug monitoring and adherence to therapies.
(11) Use of medicinal products during pregnancy and lactation.
These topics will also be discussed:
(1) Indications, dosage and timing of the medicinal products.
(2) Initiation and pharmacotherapy strategies.
(3) Side effects of drugs and their treatment.
(4) Drug-drug and drug-food interactions (clinical relevance, mechanism, solution)
(5) Comparison by class and selection of medicinal products.
(6) Co-morbidity.
(7) Contraindications.
(8) Reduction and replacement of medicinal products.
(9) New medicinal products, preparations.
(10) Drug monitoring and adherence.
(11) Use of drugs during lactation.
(12) Children and medicines.
(13) Pharmacotherapy for the elderly, development of forms.
(14) Ocular pharmacotherapy (guest rapporteur)
(15) Drug and drug addiction treatment.
(16) Hormone drugs, including contraception.
(17) Pharmacotherapy of transplant and dialysis patients.
(18) Therapy and pharmacotherapy of multiple sclerosis.
(19) Medicinal products used in a palliative context.
(20) Inflammatory bowel disease (IBD) en Irritable Bowel Syndrome (IBS) pharmacotherapy.
(21) Pharmacotherapy of mucoviscidosis.
(22) Sport and doping.
The course will have a theoretical and practical part related to the REVAPOCT COURSE offered to students.
Course Language
Italian
More information
The course is innovative, requested by students and suggested by the Italian and European related scientific societies, and is related to the new ministerial reform guidelines SSN, SSR, RSA, PHARMACIES, CRONICITA' issued in February 2021 and included in the themes of the WHO 2030 AGENDA, and will be carried out online and onsite with the collaboration of various professors from other degree courses of the University of Pavia and with the theoretical practical collaboration of FARMINDUSTRIA, FEDERFARMA, UNIVERSITA' DI CAMERINO, SCIENTIFIC SOCIETIS NATIONAL AND INTERNATIONAL AND WITH BIP
Degrees
Degrees (2)
MEDICINAL CHEMISTRY AND PHARMACEUTICAL TECHNOLOGY
Single-cycle Master’s Degree
5 years
PHARMACY
Single-cycle Master’s Degree
5 years
No Results Found
People
People
Teaching staff
No Results Found